UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia

Oncogene, 2016-12, Vol.35 (48), p.6212-6222

2016

Volltextzugriff (PDF)

980: Identification of potential biomarkers in pancreatic ductal adenocarcinoma associated to tumor–stroma interaction

European journal of cancer (1990), 2014-07, Vol.50, p.S239-S239

2014

Volltextzugriff (PDF)

PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1

Thrombosis research, 2016-04, Vol.140, p.S182-S182

2016

Volltextzugriff (PDF)

Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression

Thrombosis research, 2012-04, Vol.129, p.S193-S193

2012

Volltextzugriff (PDF)

PO-76 The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature

Thrombosis research, 2021-04, Vol.200, p.S58-S59

2021

Volltextzugriff (PDF)

Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies

Neoplasia (New York, N.Y.), 2012-09, Vol.14 (9), p.846-IN16

2012

Volltextzugriff (PDF)

PO-88 Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression

Thrombosis research, 2012-04, Vol.129, p.S193-S193

2012

Volltextzugriff (PDF)

Current understanding of the thrombospondin-1 interactome

Matrix biology, 2014-07, Vol.37, p.83-91

2014

Volltextzugriff (PDF)

Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFβ and in cooperation with PDGF

Matrix biology, 2016-09, Vol.55, p.106-116

2016

Volltextzugriff (PDF)

Soluble stroma‐related biomarkers of pancreatic cancer

EMBO molecular medicine, 2018-08, Vol.10 (8), p.n/a

2018

Volltextzugriff (PDF)

Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth

Journal of experimental & clinical cancer research, 2023-08, Vol.42 (1), p.201-201, Article 201

2023

Volltextzugriff (PDF)

CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy

Cells (Basel, Switzerland), 2020-04, Vol.9 (4), p.952

2020

Volltextzugriff (PDF)

Abstract 198: The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.198-198

2019

Volltextzugriff (PDF)

Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFß and in cooperation with PDGF

Matrix biology, 2016-09, Vol.55, p.106

2016

Volltextzugriff (PDF)

Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activity

Matrix biology, 2021-09, Vol.103-104, p.22-36

2021

Volltextzugriff (PDF)

Targeting angiogenesis with compounds from the extracellular matrix

The international journal of biochemistry & cell biology, 2011-12, Vol.43 (12), p.1674-1685

2011

Volltextzugriff (PDF)

Abstract 2981: Identification of circulating stroma-related biomarkers for pancreatic ductal adenocarcinoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2981-2981

2017

Volltextzugriff (PDF)

Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors

Scientific reports, 2016-03, Vol.6 (1), p.23432-23432, Article 23432

2016

Volltextzugriff (PDF)

Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in Mice

Cancers, 2022-04, Vol.14 (7), p.1814

2022

Volltextzugriff (PDF)

Abstract B12: Circulating stroma-related molecules as potential biomarkers for pancreatic ductal adenocarcinoma

Cancer research (Chicago, Ill.), 2015-07, Vol.75 (13_Supplement), p.B12-B12

2015

Volltextzugriff (PDF)

Abstract 3857: Patient-derived tumor xenografts as pharmacological model of human pancreatic ductal adenocarcinoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3857-3857

2017

Volltextzugriff (PDF)

Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts

Connective tissue research, 2015-09, Vol.56 (5), p.355-363

2015

Volltextzugriff (PDF)

Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies12

Neoplasia (New York, N.Y.), 2012-09, Vol.14 (9), p.846-854

2012

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(12)
Humans
(9)
Cell Biology
(7)
Adenocarcinoma
(5)
Animals
(5)
Biochemistry & Molecular Biology
(5)
Matricellular Proteins
(5)
Oncology
(5)
Tumor Microenvironment
(5)
Angiogenesis
(4)
Growth Factors
(4)
Mice
(4)
Tumors
(4)
Angiogenesis Inhibitors - Pharmacology
(3)
Cachexia
(3)
Cancer
(3)
Cell Growth
(3)
Cell Line, Tumor
(3)
Chemotherapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(4)
Matrix Biology
(4)
Thrombosis Research
(4)
Cancers
(2)
Neoplasia
(2)
Cells
(1)
Connective Tissue Research
(1)
Embo Molecular Medicine
(1)
European Journal Of Cancer
(1)
Journal Of Experimental & Clinical Cancer Research
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia

980: Identification of potential biomarkers in pancreatic ductal adenocarcinoma associated to tumor–stroma interaction

PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1

Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression

PO-76 The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature

Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies

PO-88 Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression

Current understanding of the thrombospondin-1 interactome

Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFβ and in cooperation with PDGF

Soluble stroma‐related biomarkers of pancreatic cancer

Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth

CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy

Abstract 198: The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature

Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFß and in cooperation with PDGF

Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activity

Targeting angiogenesis with compounds from the extracellular matrix

Abstract 2981: Identification of circulating stroma-related biomarkers for pancreatic ductal adenocarcinoma

Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors

Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in Mice

Abstract B12: Circulating stroma-related molecules as potential biomarkers for pancreatic ductal adenocarcinoma

Abstract 3857: Patient-derived tumor xenografts as pharmacological model of human pancreatic ductal adenocarcinoma

Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia

Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts

Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies12

Suchergebnisse filtern